A clinical trial assessing serotonin 2A receptor agonists
Latest Information Update: 24 Sep 2021
At a glance
- Drugs Serotonin 5-HT2A receptor agonists (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions
- Sponsors Bright Minds Biosciences
- 24 Sep 2021 New trial record
- 22 Sep 2021 According to Bright Minds Biosciences media release, this trial is targeted for 2H 2022;